Compare PCRX & JBSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | JBSS |
|---|---|---|
| Founded | 2006 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 927.1M |
| IPO Year | 2010 | 1994 |
| Metric | PCRX | JBSS |
|---|---|---|
| Price | $23.78 | $81.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $30.25 | ★ $109.00 |
| AVG Volume (30 Days) | ★ 518.7K | 56.1K |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.10% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.16 | ★ 3.12 |
| Revenue | $541,533,000.00 | ★ $1,107,246,000.00 |
| Revenue This Year | $6.78 | $5.58 |
| Revenue Next Year | $8.54 | N/A |
| P/E Ratio | $150.19 | ★ $25.79 |
| Revenue Growth | ★ 26.04 | 3.79 |
| 52 Week Low | $18.80 | $59.07 |
| 52 Week High | $27.99 | $85.15 |
| Indicator | PCRX | JBSS |
|---|---|---|
| Relative Strength Index (RSI) | 57.59 | 56.24 |
| Support Level | $23.74 | $61.12 |
| Resistance Level | $23.94 | $81.93 |
| Average True Range (ATR) | 0.73 | 2.53 |
| MACD | 0.11 | 0.23 |
| Stochastic Oscillator | 75.36 | 66.89 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.